Table 2. Approaches to target E3 ubiquitin ligase activity in CRC.
Compound | Class | Target | Proposed working mechanism | Refs |
---|---|---|---|---|
R-spondin | Protein/peptide | RNF43/ZNRF3 | Neutralizes receptors and upregulates Wnt signaling | 41 |
C59 | porcupine inhibitor | Mutant RNF43/ZNRF3 | Blocks Wnt niche function | 131, 132 |
LGK974 | Small molecule Porcupine inhibitor | RNF43/ZNRF3 | Prevents palmitylation of Wnt proteins and inhibits Wnt signaling | 131, 132 |
HLI98 | Small molecule | MDM2 | Inhibits MDM2 ubiquitin, activates p53 pathway and induces apoptosis | 141 |
MX69 | Small molecule | MDM2/XIAP | Degrades MDM2, activates p53 and inhibits XIAP | 142 |
Ceramide/LCL85 | Small molecule | cIAP1/XIAP | Induces proteasomal degradation of cIAP1 and XIAP | 143 |
MLN4924 | Small molecule | SCF E3 ubiquitin ligases | Induces G2/M arrest, apoptosis and DNA damage; inhibition of cullin neddylation | 146, 147 |
CC0651 | Small molecule | E2 enzyme hCdc34 and SCF subunits Skp1, Cul1 and Rbx1 | Causes the SCFSkp2 substrate p27Kip1 accumulation | 149, 150 |
Pro-TAME | Small molecule | APC/Cdc20 | Disruption of the APC/Cdc20 interaction leading to lower APC/C activity on substrates | 151, 152, 153 |
Abbreviations: APC/C, anaphase-promoting complex/cyclosome; CRC, colorectal cancer; SCF, S phase kinase-associated protein 1–cullin1–F-box protein; XIAP, X-chromosome-linked apoptotic protein.